Syncona Portfolio Ltd

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Syncona Portfolio Ltd reported 3 stock positions worth $80.7 million. Its top holding was Autolus Therapeutics (AUTL) at 83.4% of the portfolio, followed by Achilles Therapeutics PL-ADR (ACHL, 14.0%) and Century Therapeutics (IPSC, 2.6%). Compared with Q2 2024, it added to 1 and reduced 1. The biggest buy was Century Therapeutics (IPSC, shares +21%) and the biggest sale Autolus Therapeutics (AUTL, shares −13%).

Most Recent 13F
Q2 2026
Location
St Peter Port, Guernsey, X0
CIK
0001725042
Portfolio Value
$80.7M (Q3 2024)
SEC Filing
0000950123-24-011626 ↗ filed Nov 14, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $150.1M Q1 2024 Q2 2024: $85.9M Q2 2024 Q3 2024: $80.7M $80.7M Q3 2024 Q4 2024: $53.0M Q4 2024 Q1 2025: $26.4M Q1 2025 Q2 2025: $38.6M Q2 2025 Q3 2025: $27.7M Q3 2025 Q4 2025: $34.3M Q4 2025 Q1 2026: $25.7M Q1 2026 Q2 2026: $26.6M Q2 2026

Holdings 3 stocks · $80.7M
AUTL Autolus Therapeutics PLC 83.42% 18,554,624 $67.4M Reduce -13.1%
ACHL Achilles Therapeutics PL-ADR 14.01% 11,086,909 $11.3M No change
IPSC Century Therapeutics Inc. 2.57% 1,213,056 $2.1M Add +21.2%

Portfolio Sells Q2 2024 → Q3 2024
AUTL Autolus Therapeutics PLC Reduce -13.1% 83.42% −3.08

Portfolio Buys Q2 2024 → Q3 2024
IPSC Century Therapeutics Inc. Add +21.2% 2.57% −0.40

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$26.6MAUTL
Q1 2026 2$25.7MAUTL, IPSC
Q4 2025 2$34.3MAUTL, IPSC
Q3 2025 2$27.7MAUTL, IPSC
Q2 2025 2$38.6MAUTL, IPSC
Q1 2025 2$26.4MAUTL, IPSC
Q4 2024 3$53.0MAUTL, ACHL, IPSC
Q3 2024 3$80.7MAUTL, ACHL, IPSC
Q2 2024 3$85.9MAUTL, ACHL, IPSC
Q1 2024 2$150.1MAUTL, ACHL